KALV: KalVista Pharmaceuticals O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
KalVista Pharmaceuticals (KALV) aksiyalarining narx dinamikasi uning tijoratdan oldingi holati va daromadli emasligi bilan belgilanadi. P/E to G o'sishni baholash ko'rsatkichi joriy tebranishlarni aks ettiradi, bunda 0.00 bazaviy qiymat sifatida qayd etilgan. Kompaniyaga tegishli istiqbollar molekulalarni kashf qilishga AI texnologiyalarini integratsiya qilishga hamda bozor ulushini egallash uchun irsiy angioedemaning innovatsion oral davolash vositasi uchun FDA tasdig'ini kutishga bog'liq.
KalVista Pharmaceuticals (KALV) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi kalvista.com|KALV - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar KalVista Pharmaceuticals Inc|KALV - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari KalVista Pharmaceuticals|Tezkor likvidlik koeffitsiyenti kalvista.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
KALV - Kompaniyaning sof foydasi|Kutilayotgan foyda KalVista Pharmaceuticals|KALV - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati KalVista Corp|KALV - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati KalVista Pharmaceuticals Inc|KALV - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda KalVista Pharmaceuticals|KALV - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati kalvista.com|KALV - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi KalVista Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:KALV - KalVista Pharma
Faoliyat ko'lami laboratoriya standartlari bilan cheklangan kichik tadqiqot firmasi KalVista Pharmaceuticals (KALV) uchun foyda dinamikasiga nisbatan baholash kritik ahamiyatga ega. Ushbu koeffitsient joriy P/E ko'paytirgichini kutilaygan o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymat aktivning fundamental jihatdan past baholanganligidan dalolat beradi. Tarixiy PEG darajalarini tahlil qilish investorga aksiyalar narxini korporativ rejalar bajarilmasligi xavflari bilan muvozanatga keltirgan holda, potentsial "raketalar"ni aniqlash imkonini beradi.
KalVista Pharmaceuticals raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|PHVS - PEG multiplikatori|ABCL: PEG multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|Narxning foydaga va o‘sish sur’atiga nisbati UPB (Upstream Pharma)|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Septerna, Inc. SEPN|PVLA (Pieris Pharmaceuticals Inc) - Narx-foyda va o‘sish multiplikatori|SVRA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|PEG multiplikatori anaptysbio.com|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati RAPT Therapeutics, Inc. RAPT|JBIO (Aerovate Therapeutics, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA: PEG multiplikatori|Cabaletta Bio Inc. (CABA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|THTX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|Narx-foyda va o‘sish multiplikatori eledon.com ELDN|PEG multiplikatori AGEN (Agenus Inc.)|PEG multiplikatori Climb Bio Inc. CLYM|Zura Bio Limited - PEG multiplikatori|aTyr Pharmaceuticals (ATYR) - Narx-foyda va o‘sish multiplikatori|ADAG: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ikena Oncology (IMA)|Narx-foyda va o‘sish multiplikatori STTK|PEG multiplikatori Equillium Bio|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IMUX|PEG multiplikatori ATRA (Atara Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. - PEG multiplikatori|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narxning foydaga va o‘sish sur’atiga nisbati KZR|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Akari Therapeutics PLC|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|PEG multiplikatori Q32 Bio Inc QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|CARM (Carisma Therapeutics Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori XTLB|Narxning foydaga va o‘sish sur’atiga nisbati BOLT|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|PEG multiplikatori CALI|PEG multiplikatori affimed.com (AFMD)|Allakos - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
